Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion
Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft
Substitutes) Application (Orthopedic, Gynecology, Cardiovascular,
Reconstructive)
Biosurgery market to
grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a
Compound Annual Growth Rate (CAGR) of 6.5%.
Market Growth Drivers:
1. Rising Geriatric Population
2. Increasing Volume of Surgeries
3. Increasing Prevalence of Severe Trauma Injuries
4. Strong Focus on R&D Leading to the Launch of New and Advanced Products
5. Rising Need for Effective Blood Loss Management in Patients
6. Untapped Emerging Markets
Objective of Study:
1. To define, describe, and segment the global market by product &
service, technology, application, end user and region.
2. To provide detailed information about factors influencing market growth (drivers,
restraints, and opportunities).
3. To analyze micromarkets with respect to individual growth trends, prospects,
and contributions to the global industry
4. To analyze market opportunities for stakeholders and provide details of the
competitive landscape for key players.
5. To forecast the size of the market segments with respect to four major
regional segments, namely, North America, Europe, Asia Pacific (APAC), and the
Rest of the World (RoW).
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302
In-Depth Market Segmentation:
Products:
The biosurgery market, by product, is segmented
into bone-graft substitutes, soft-tissue attachments, surgical sealants and
adhesives, hemostatic agents, adhesion barriers, and staple-line reinforcement
agents. Among the products segment, the surgical sealants and adhesives segment
is expected to grow at the highest CAGR during the forecast period. The total
number of surgeries being performed annually is increasing owing to the growing
geriatric population, rising prevalence of lifestyle diseases (such as cardiovascular
and orthopedic diseases), and growing number of people suffering from lower
back pain and sports-related injuries, thereby attributing to high growth of
this segment.
Applications:
On the basis of applications, the biosurgery market is segmented into
neurological surgery, cardiovascular surgery, general surgery, orthopedic
surgery, thoracic surgery, gynecological surgery, urological surgery, and
reconstructive surgery. The orthopedic surgery segment is expected to account
for the largest share of the biosurgery market during the forecast period. The
large share of this segment can be attributed to the large number of orthopedic
bone and soft tissue repair surgeries being performed globally, on an annual
basis. The growing number of orthopedic surgeries is in turn expected to
support the growth of dependent markets, such as the biosurgery market for
orthopedic applications.
Geographic Growth Analysis:
Detailed analysis of market in European countries such as the UK, Germany,
France, Italy, Spain, and others.
Detailed analysis of industry in Asia Pacific countries such as China, Japan,
India, and others.
North America is expected to hold the largest
market size in the biosurgery market during the forecast period. The highest
market share of North America is due to the presence of a well-developed
healthcare system, increasing volume of surgical procedures performed, large
number of hospitals, and presence of leading market players in the region. The
Asia Pacific market is expected to witness the highest growth rate during the
forecast period.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302
Key Players:
Baxter International (US), Johnson & Johnson
(J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US),
Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global
biosurgery market. Some of the other leading players in this market include
Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun
Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife
Inc. (US).
Baxter International (US) dominates the global biosurgery market with the
largest share in 2017. The company offers wide portfolio in biosurgery market,
and further seeks to strengthen its product offerings through product
enhancements and by expanding its advanced surgery product portfolio which
includes FLOSEAL Hemostatic Matrix and TISSEEL through product acquisitions in
April 2017.
